There is no cure.

Treatments, often, don't work.

There is hope. 

Vitiligo is a dermatological condition characterized by the appearance of white patches of skin on different parts of the body, such as the face, hands, arms and feet, and is a result of the absence of functional pigment cells (melanocytes). Vitiligo can cause severe cosmetic distress and is associated with social stigma, profound psychological impact and affects quality of life1.  People who have vitiligo can feel embarrassed, ashamed, depressed or worried about how others will react2. Severe depression from vitiligo has been known to lead to suicide attempts1.

About 0.5-1% of the world’s population has vitiligo2, with 2-5 million in the United States3. There is no cure. Although many treatment options are available to help restore skin color, (topical creams, systemic treatments, phototherapy, surgical skin grafting etc.) results vary widely between individuals and are often unsatisfactory4.

TeVido Biodevices aims to change that.   By creating a centralized therapy-as-a-service (TAAS) facility, TeVido will prepare cultured autologous melanocyte transplants for any physician, removing the need for the physician to staff and build infrastructure themselves, thereby enabling therapy for the masses. By serving many patients being treated by multiple physicians, TeVido will significantly enhance patient’s access to treatment while addressing regulatory concerns of culturing cells. 

 

Video courtesy of Vitiligo Working Group (VWG)

 

1. Parsad, D., Dogra, S. & Kanwar, A. J. Quality of life in patients with vitiligo. Health Qual. Life Outcomes 1, 58 (2003).
2. Rich Clark, O. of C. and P. L. Questions and Answers about Vitiligo. National Institute of Arthritis and Musculoskeletal and Skin Diseases (2014). Available at: http://www.niams.nih.gov/health_info/vitiligo/#8. (Accessed: 13th June 2016)
3. Frequently Asked Questions About Vitiligo (FAQ). Vitiligo Support International Inc Available at: https://www.vitiligosupport.org/faq.cfm#item1. (Accessed: 13th June 2016)
4. Ezzedine, K., Eleftheriadou, V., Whitton, M. & van Geel, N. Vitiligo. Lancet 386, 74–84 (2015).
5. Savant, S. S. Surgical therapy of vitiligo: current status. Indian J. dermatology Venereol. Leprol. 71, 307–310 (2008)

Return to Home